Insider Selling: Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Major Shareholder Sells 47,039 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 47,039 shares of the company’s stock in a transaction on Monday, May 12th. The stock was sold at an average price of $5.72, for a total transaction of $269,063.08. Following the transaction, the insider now owns 1,447,191 shares of the company’s stock, valued at approximately $8,277,932.52. The trade was a 3.15% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Tuesday, April 1st, J.H. Whitney Equity Partners V sold 5,580 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.63, for a total transaction of $31,415.40.
• On Monday, March 24th, J.H. Whitney Equity Partners V sold 268 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.63, for a total transaction of $1,508.84.
• On Tuesday, March 18th, J.H. Whitney Equity Partners V sold 61,564 shares of Aveanna Healthcare stock. The shares were sold at an average price of $5.51, for a total value of $339,217.64.

Aveanna Healthcare Trading Down 0.7%

Shares of Aveanna Healthcare stock opened at $5.82 on Thursday. The company has a 50-day moving average of $4.95 and a two-hundred day moving average of $4.91. Aveanna Healthcare Holdings Inc. has a 12-month low of $2.32 and a 12-month high of $6.19. The stock has a market cap of $1.14 billion, a PE ratio of -17.12 and a beta of 2.01.

Institutional Investors Weigh In On Aveanna Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of AVAH. Price T Rowe Associates Inc. MD boosted its position in Aveanna Healthcare by 5.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 53,699 shares of the company’s stock worth $246,000 after purchasing an additional 2,649 shares in the last quarter. Rhumbline Advisers boosted its position in shares of Aveanna Healthcare by 4.0% in the 1st quarter. Rhumbline Advisers now owns 75,581 shares of the company’s stock worth $410,000 after buying an additional 2,918 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its stake in Aveanna Healthcare by 15.7% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 25,171 shares of the company’s stock valued at $115,000 after acquiring an additional 3,407 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Aveanna Healthcare by 0.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 466,706 shares of the company’s stock valued at $2,133,000 after acquiring an additional 4,047 shares in the last quarter. Finally, MetLife Investment Management LLC increased its holdings in Aveanna Healthcare by 16.2% during the 1st quarter. MetLife Investment Management LLC now owns 31,251 shares of the company’s stock valued at $169,000 after acquiring an additional 4,349 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on AVAH shares. UBS Group increased their target price on Aveanna Healthcare from $4.50 to $5.00 and gave the stock a “sell” rating in a research note on Friday, May 9th. Truist Financial cut their price objective on Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating for the company in a research report on Friday, April 11th.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.